HologicFRA:HO1 57 Interest Coverage is 8.73 as of Dec. 2025, which is 27% above its 10-year median of 6.85. GuruFocus rates FRA:HO1 with a GF Score™ of 57/100 and a GF Value™ of €70.17. The stock has 4 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Hologic ranks worse than 69.87% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Hologic's
Operating Income
for the
three
months ended in Dec. 2025 was €206 Mil. Hologic's Interest Expense for the
three
months ended in Dec. 2025 was €-24 Mil.
Hologic's interest coverage for the quarter that ended in Dec. 2025 was 8.73.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Hologic's Interest Coverage or its related term are showing as below:
FRA:HO1'
s Interest Coverage Range Over the Past 10 Years
Min: 3.16 Med: 6.85 Max: 26.53
Current: 6.94
FRA:HO1's Interest Coverage is ranked worse than 69.87% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs FRA:HO1: 6.94
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Hologic Interest Coverage Related Terms
Hologic Interest Coverage Historical Data
* Premium members only.
The historical data trend for Hologic's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
FRA:HO1 vs WST, COO, ALGN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Hologic's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Hologic's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic (FRA:HO1) has a Interest Coverage of 8.73 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hologic and its competitors. This is 27% above median its historical median of 6.85. Over the past decade, Hologic's Interest Coverage has ranged from 3.16 to 26.53. According to the industry distribution chart, Hologic ranks #327 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 69.9%.
Is Hologic's Interest Coverage too high?
Hologic's current Interest Coverage of 8.73 is 27% above median its 10-year median of 6.85. Over the past 10 years, this metric has ranged from a low of 3.16 to a high of 26.53. The Medical Devices & Instruments industry median Interest Coverage is 15.71. Hologic's value of 8.73 is 44.4% below this industry median. Based on the distribution chart, Hologic ranks #327 out of 468 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's Interest Coverage compare to WST and COO?
According to the Medical Devices & Instruments industry distribution chart, Hologic ranks #327 out of 468 companies for Interest Coverage. This places Hologic in the lower half of its industry. The industry median Interest Coverage is 15.71. Hologic's value of 8.73 is 44.4% below this benchmark. Historically, Hologic's own Interest Coverage has ranged from 3.16 to 26.53 over the past decade. While the company's 10-year median is 6.85 vs. the industry median of 15.71, Hologic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hologic's current Interest Coverage of 8.73 is 44.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hologic and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hologic's current Interest Coverage is 8.73, which is 27% above median its own 10-year median of 6.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (FRA:HO1) has a current Interest Coverage of 8.73. The stock's GF Value™ is €70.17, compared to a current price of €65.00 — trading 7.4% below its estimated fair value. The current Interest Coverage is 8.73, which is 27% above median its 10-year median of 6.85 and 44.4% below the Medical Devices & Instruments industry median of 15.71. Hologic's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Hologic (FRA:HO1), the current Interest Coverage is 8.73 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hologic (FRA:HO1) Overvalued in 2026?
Based on GuruFocus' analysis, Hologic stock appears to be undervalued.
The current stock price of €65.00 is trading 7.4% below its estimated GF Value™ of €70.17.
Key valuation signals for FRA:HO1:
Interest Coverage: 8.73 (27% above median its 10-year median of 6.85)
GF Value™: €70.17 vs. price of €65.00 (7.4% below fair value)
Industry Position: 44.4% below the Medical Devices & Instruments median (#327 of 468)
No single metric tells the full story. See the FRA:HO1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score
Get the complete analysis for FRA:HO1
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HO1 has been successfully added to your 
